why choose us

First received: August 15, 2023

Clinical Trial: Biological Effects of Quercetin in COPD Phase II

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Chronic Obstructive Pulmonary Disease

Study Type: INTERVENTIONAL


Official Title: Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II

Brief Summary: This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease.It is small study with 8 subjects receiving quercetin 1000 mg/day, 8 patients receiving 500 mg/day and 4 subjects receive placebo.

Read more